Search clinical trials for: open label placebo (OLP) treatment

Total 115266 results

University Hospital, Basel, Switzerland

Recruiting

Boosting Open-Label Placebo Effects in Acute Induced Pain in Healthy Adults (BOLPAP)

Acute Pain

Switzerland
OliPass Australia Pty Ltd
Novotech (Australia) Pty Limited

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002

Osteoarthritis

Australia
Philipps University Marburg Medical Center

Completed

Investigating Hope and Expectations in Open-Label Placebos (I-HELP)

Pain

Germany
InQpharm Group

Completed

Clinical Benefit of a Mouthrinse for the Treatment of Dentine Hypersensitivity

Dentin Sensitivity

Germany
Peking University Third Hospital

Recruiting

The Regulatory Role of Immune Response in Oral Lichen Planus

Oral Lichen Planus

China
University of Alabama at Birmingham

Completed

Open-Label Placebos to Treat Fatigue in Multiple Sclerosis

Multiple Sclerosis | Fatigue

United States
Philipps University Marburg Medical Center

Completed

Components of Placebo Effects in Sadness (COPES)

Dysphoric Mood

Germany
Qazvin University Of Medical Sciences

Unknown

Free Soft Tissue Graft in Treatment of Oral Lichen Planus (TOLP)

Oral Lichen Planus

Iran, Islamic Republic of
University Hospital, Basel, Switzerland
Prof. Dr., Jens Gaab, Division of Clinical Psychology and Psychotherapy,... and other collaborators

Completed

Taking Open Label Placebo Further: Trial of Imaginary Pills in Test Anxiety

Test Anxiety

Switzerland
University Hospital, Basel, Switzerland

Completed

Open-Label Placebo Treatment for Acute Postoperative Pain (OLP-POP)

Postoperative Pain

Switzerland
Lipella Pharmaceuticals, Inc.

Not yet recruiting

Evaluating LP-10 in Subjects With OLP

Oral Lichen Planus
Heilongjiang University of Chinese Medicine

Unknown

Based on Metabonomics Dryness Pathogen Type of OLP: a Dynamic Study (OLP)

Oral Lichen Planus
University of Maryland, Baltimore
University of Maryland, College Park

Completed

Harnessing Placebo Effects in Methadone Treatment

Opioid-Related Disorders | Opioid-use Disorder

United States
OliPass Corporation

Completed

OLP-1002 is Being Studied in the Treatment of Pain.

Pain

United Kingdom
OliPass Corporation
Novotech (Australia) Pty Limited

Recruiting

Study of OLP-1002 Injections for Reducing Moderate to Severe Pain Due to Osteoarthritis in Hip and/or Knee Joint

Osteoarthritis

Australia
Koite Health Oy
University of Helsinki; Tampere University; Tampere University Hospital; Wellbeing...

Recruiting

Dual-light Antibacterial Photodynamic Therapy as an Adjunctive Treatment to Corticosteroid Treatment in OLP (RELIEF-OLP)

Oral Bacterial Infection | Dental Plaque | Oral Lichen Planus

Finland
TransMedics

Recruiting

Sponsor-Initiated OCS Liver Perfusion (OLP-II) Registry (OLP-II)

Liver Transplant

United States
University of Alabama at Birmingham

Withdrawn

OLP to Manage Pain in TJA: A Feasibility Study

Opioid Dependence | Opioid Abuse
University of California, San Francisco

Recruiting

A Neuroimaging Study of Open-label Placebo in Depressed Adolescents (OLP)

Depression

United States
Jaylane kadry Ghonima

Unknown

Matrix Metalloproteinases Neutralizing Agents in Oral Lichen Planus

Oral Lichen Planus

Egypt
University Health Network, Toronto

Completed

RCT:Oropharyngeal Leak Pressure (OLP) - Ambu AuraGain vs LMA Supreme (OLP-Aur/Sup)

Laryngeal Masks

Canada
Taipei Medical University

Active, not recruiting

Effects of Bifidobacterium Longum OLP-01 Supplement on Cognitive Function, Exercise Performance, Nutritional Status and Gut Microbiota in Stroke Patients

Stroke

Taiwan
University of Faisalabad

Unknown

Treatment Modalities of Oral Lichen Planus (OLP)

Oral Lichen Planus

Pakistan
TransMedics

Active, not recruiting

OCS Liver Perfusion (OLP) Post-Approval Registry

Liver Transplant

United States
Cairo University

Completed

Efficacy of Intralesional Injection of Platelet Rich Plasma in the Treatment of Patients With Erosive Oral Lichen Planus

Erosive Oral Lichen Planus

Egypt
University of Erlangen-Nürnberg Medical School

Recruiting

Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore (PREDICT-OLP)

Oral Leukoplakia | Oral Lichen Planus | Oral Leukoplakia of Tongue | Oral Leukoplakia of Gingiva

Germany
October 6 University
Cairo University

Recruiting

Efficacy of Probiotic Capsules With Topical Clobetasol Propionate in OLP Treatment

Oral Lichen Planus

Egypt
Dermtreat
X-act Cologne Clinical Research GmbH; Proinnovera GmbH

Completed

Intra-oral Treatment of OLP With Rivelin®-CLO Patches

Oral Lichen Planus

Denmark, United States, Canada, Germany, Ireland, United Kingdom
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults

Cardiovascular Disease

United States
Cairo University

Completed

Evaluation of Salivary Level of miR-155 and IL-10 in Oral Lichen Planus Patients Before and After Treatment With Topical Corticosteroid

Oral Lichen Planus

Egypt
Cairo University

Unknown

Evaluation of Topical Chamomile Versus Topical Triamcinolone Acetonide in Management of Oral Lichen Planus

Oral Lichen Planus
NHS Tayside

Terminated

AuraGain and iGel Crossover Comparison

Airway Management | Laryngeal Mask Airway

United Kingdom
B.P. Koirala Institute of Health Sciences

Completed

A Clinical Trial to Study the Effects of Two Drugs, Lycopene and Prednisolone in Patients With Oral Lichen Planus (OLP)

Oral Lichen Planus
University of California, San Francisco

Not yet recruiting

Open-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis

Adolescent Idiopathic Scoliosis (AIS)

United States
Studio Osteopatico Busto Arsizio

Recruiting

Open-label Placebo in Manual Therapy

Low Back Pain, Recurrent

Italy
AstraZeneca

Recruiting

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) (DAISY)

Systemic Sclerosis | Scleroderma

United Kingdom, United States, Italy, Mexico, Belgium, Germany, Spain, China, France, India, Austria, Canada, Poland, Israel, Korea, Republic of, Hungary, Japan, South Africa, Turkey, Netherlands, Romania
Novartis Pharmaceuticals

Recruiting

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

Chronic Spontaneous Urticaria

United States, Singapore, Spain, Germany, Turkey, Italy, Hong Kong, China, Malaysia, Argentina, Thailand, Poland, Japan, Netherlands, Chile, Canada
Novartis Pharmaceuticals

Recruiting

An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

Chronic Spontaneous Urticaria

United States, Korea, Republic of, Spain, France, Germany, Bulgaria, United Kingdom, Italy, China, Hungary, Czechia, Turkey, Argentina, Colombia, Denmark, Japan, Taiwan, Australia, Singapore, Switzerland, Russian Federation, Thailand and more
Cairo University

Not yet recruiting

Effect of Adjunctive Use of Vitamin B3 and B9 on Myeloperoxidase Level in the GCF of Patients With Stage I and II Periodontitis

Periodontitis | Periodontal Diseases | Periodontal Attachment Loss | Periodontal Inflammation | Periodontitis Stage I | Periodontitis Stage II
University of Utah

Recruiting

Sphenopalatine Ganglion Block for the Treatment of Post-Stroke Headache

Stroke | Ischemic Stroke | Headache

United States
Universitätsklinikum Hamburg-Eppendorf
University Hospital, Essen; Philipps University Marburg Medical Center; Helmut...

Recruiting

Combined N-of-1 Trials to Assess Open-Label Placebo Treatment for Antidepressant Discontinuation Symptoms (FAB)

Depressive Symptoms | Expectations | Antidepressants

Germany
Amber Ophthalmics, Inc.

Recruiting

NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular Chemical and/or Thermal Injuries (EXPEDE)

Corneal Persistent Epithelial Defect

United States
Pfizer

Completed

A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA

Arthritis Juvenile Idiopathic

United States, Belgium, Spain, Canada, Mexico, Turkey, Israel, China, Slovakia, Hungary, India, Argentina, Brazil, Germany, South Africa, Poland, Ukraine, Italy, Costa Rica, Russian Federation, United Kingdom
Novartis Pharmaceuticals

Completed

A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1- Antihistamines (REMIX-2)

Chronic Spontaneous Urticaria

United States, India, Malaysia, Taiwan, Poland, United Kingdom, China, Thailand, Switzerland, Germany, Vietnam, Brazil, Russian Federation, Slovakia, Denmark, Canada, South Africa, Austria
Novartis Pharmaceuticals

Completed

A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines (REMIX-1)

Chronic Spontaneous Urticaria

Hungary, Taiwan, Italy, Korea, Republic of, Australia, France, Bulgaria, Czechia, Turkey, India, United States, Argentina, Mexico, Spain, Japan, Colombia, Russian Federation, Singapore, Puerto Rico
Beth Israel Deaconess Medical Center
National Center for Complementary and Integrative Health (NCCIH)

Completed

Effects of Open-label vs Double-blind Treatment in IBS

Irritable Bowel Syndrome | Placebo Effect | Placebos | Peppermint Oil

United States
Bristol-Myers Squibb

Completed

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis

Rheumatoid Arthritis | Systemic Lupus Erythematosus | Autoimmune Disorder | Primary Sjögren's Syndrome

United States, Argentina, Belgium, France, Germany, Mexico, Poland, Spain, Netherlands, United Kingdom
Merck Sharp & Dohme LLC

Active, not recruiting

Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008, KEYVIBE-008)

Small Cell Lung Carcinoma

United States, Poland, Israel, Argentina, Australia, Austria, Canada, China, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Korea, Republic of, Lithuania, Mexico, Netherlands, Portugal, Romania, Spain, Turkey, United...
Merck Sharp & Dohme LLC
Eisai Inc.

Active, not recruiting

Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)

Nonsquamous Non-small Cell Lung Cancer

United States, Argentina, Australia, Canada, Chile, China, France, Germany, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, United Kingdom
Merck Sharp & Dohme LLC

Completed

Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598)

Carcinoma, Non-Small-Cell Lung

United States, Ireland, Argentina, Australia, Brazil, Canada, Chile, Colombia, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Peru, Poland, South Africa, Spain, Taiwan, Thailand, Turkey, Ukraine, United Kingdom

Search clinical trials for: open label placebo (OLP) treatment

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations